ArticleJournal of inflammation research2025
IgG-Associated Hypocomplementemia in Neonatal Lupus: A Retrospective Multicenter Study.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gut microbiota functional remodeling and butyrate depletion amplify anti-Ro/La antibody-driven type I interferon activation in neonatal lupus.Gut microbes · 2026Article
- Immunological and clinical characteristics of severe thrombocytopenia in neonates with Kasabach-Merritt phenomenon.Frontiers in immunology · 2026Article
- Seizure phenotypes and short-term prognosis in neonatal lupus: a multicenter retrospective cohort in China.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypocomplementemia, defined as a complement C3 or C4 level below the normal lower limit, is strongly associated with an unfavorable prognosis in patients with autoimmune diseases. This study aimed to explore the clinical features and outcomes of patients with neonatal systemic lupus erythematosus (NLE) with hypocomplementemia. Methods: This retrospective clinical study was conducted across four tertiary hospitals in Eastern China on January 1, 2011, and December 31, 2023. This study included 91 patients with NLE. Patients were classified into hypocomplementemic and non-hypocomplementemic groups according to their serum C3 and/or C4 levels. Risk factors for the development of hypocomplementemia were explored using univariate/multifactorial analyses, organ involvement, and follow-up outcomes were compared between groups. Results: The number of NLE patients with hypocomplementemia was 36 (39.56%). Hypocomplementemia group had a significantly lower proportion of fish oil supplementation during pregnancy, a higher proportion of cesarean deliveries, mothers with systemic lupus erythematosus, double antibody positivity for anti-SSA and anti-SSB, and higher serum IgG levels. Multivariate analyses showed that maternal allergic diseases, double antibody positivity, and serum IgG levels were risk factors for hypocomplementemia. Baseline IgG levels negatively correlated with complement C3 and C4 levels. NLE Patients with hypocomplementemia are more likely to have thrombocytopenia, hypoproteinemia, or gastrointestinal involvement than those without hypocomplementemia. Systemic application of glucocorticoids was significantly more prevalent in the hypocomplementemia group. Long-term follow-up revealed that allergy-associated disorders were common in patients with NLE and hypocomplementemia, followed by developmental delay, severe infections, attention- deficit hyperactivity disorder, and anxiety/depression, respectively. Log-rank analysis revealed that these patients had significantly higher frequencies of allergic diseases and developmental delays later in life. Conclusion: Maternal allergic diseases, double antibody positivity, and serum IgG levels were associated with the development of hypocomplementemia in children with NLE. Patients with hypocomplementemia-associated NLE typically exhibit a more severe disease course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.